The Rise Of Biosimilar Pharmaceuticals In Latin America
Globally, biologic medicine sales have boosted the revenue growth of many major pharmaceutical companies. In emerging markets, however, pharma giants will face increasing competition as governments support the development of local biopharmaceutical industry. We highlight Brazil as one country where domestic firms selling biosimilar drugs have become competitive players that will eventually threaten multinationals' regional revenue growth. This week's podcast features Shanshan Wang, an analyst with our Pharmaceutical & Healthcare research team.